dihexa cancer risk hgf c-met Targeting cancer-associated fibroblast-activated HGF/c-MET pathway inhibits extrahepatic cholangiocarcinoma progression and restores gemcitabine therapeutic sensitivity Brain Support Gut Feeling Peptides Capsules Color:Pink

dihexa cancer risk hgf c-met Targeting cancer-associated fibroblast-activated HGF/c-MET pathway inhibits extrahepatic cholangiocarcinoma progression and restores gemcitabine therapeutic sensitivity Brain Support Gut Feeling Peptides Capsules Color:Pink

Gut Feeling Peptides Capsules

Another phase II, randomized, open-label clinical trial revealed no difference in survival for the combination of ramucirumab and eribulin versus eribulin monotherapy in patients with advanced breast cancer (Yardley et al., 2016b)

Brain Support

Color:Pink

Home monitoring with Amsler grid (detects central vision distortion) for AMD patients